STRS Ohio’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-58,000
| Closed | -$299K | – | 2220 |
|
|
2019
Q2 | $299K | Buy |
58,000
+57,600
| +14,400% | +$259K | ﹤0.01% | 1585 |
|
|
2019
Q1 | $1K | Hold |
400
| – | – | ﹤0.01% | 2044 |
|
|
2018
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 2063 |
|
|
2018
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 2099 |
|
|
2018
Q2 | $1K | Hold |
400
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q1 | $1K | Hold |
400
| – | – | ﹤0.01% | 1870 |
|
|
2017
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 1871 |
|
|
2017
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 1911 |
|
|
2017
Q2 | $2K | Hold |
400
| – | – | ﹤0.01% | 1923 |
|
|
2017
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 1878 |
|
|
2016
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 1907 |
|
|
2016
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 1893 |
|
|
2016
Q2 | $2K | Hold |
400
| – | – | ﹤0.01% | 1909 |
|
|
2016
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 1888 |
|
|
2015
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 1905 |
|
|
2015
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 1867 |
|
|
2015
Q2 | $6K | Hold |
400
| – | – | ﹤0.01% | 1847 |
|
|
2015
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 1785 |
|
|
2014
Q4 | $7K | Hold |
400
| – | – | ﹤0.01% | 1715 |
|
|
2014
Q3 | $4K | Hold |
400
| – | – | ﹤0.01% | 1773 |
|
|
2014
Q2 | $6K | Hold |
400
| – | – | ﹤0.01% | 1680 |
|
|
2014
Q1 | $7K | Hold |
400
| – | – | ﹤0.01% | 1697 |
|
|
2013
Q4 | $8K | Sell |
400
-2,600
| -87% | -$52.8K | ﹤0.01% | 1722 |
|
|
2013
Q3 | $49K | Buy |
+3,000
| New | +$31.5K | ﹤0.01% | 1729 |
|
Other funds holding PETX
STRS Ohio's PETX Position: Q3 2019 in Review
STRS Ohio sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 58,000 shares — an estimated $299K sold.
STRS Ohio first reported a position in PETX in Q3 2013 and held it in 24 quarters. The position peaked at $299K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- STRS Ohio reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- STRS Ohio sold 58,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $299K.
- STRS Ohio first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and held it in 24 quarters.
- STRS Ohio's Aratana Therapeutics, Inc. position peaked at $299K in Q2 2019.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on STRS Ohio's 13F filing for Q3 2019, filed 21 Oct 2019.